DOW JONES23,433.57+779.71 3.44%
S&P 5002,749.98+90.57 3.41%
NASDAQ8,090.90+203.64 2.58%

BioXcel Therapeutics Q4 EPS $(0.45) Up From $(0.46) YoY

BioXcel Therapeutics (NASDAQ:BTAI) reported quarterly losses of $(0.45) per share. This is a 2.17 percent increase over losses of $(0.46) per share from the same period last year.

Benzinga · 03/09/2020 11:08

BioXcel Therapeutics (NASDAQ:BTAI) reported quarterly losses of $(0.45) per share. This is a 2.17 percent increase over losses of $(0.46) per share from the same period last year.